JP2017526742A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2017526742A5 JP2017526742A5 JP2017527980A JP2017527980A JP2017526742A5 JP 2017526742 A5 JP2017526742 A5 JP 2017526742A5 JP 2017527980 A JP2017527980 A JP 2017527980A JP 2017527980 A JP2017527980 A JP 2017527980A JP 2017526742 A5 JP2017526742 A5 JP 2017526742A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- fragments
- optionally
- fragments derived
- tuberculosis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| BG11180414 | 2014-08-15 | ||
| BG111804 | 2014-08-15 | ||
| BG11204515 | 2015-06-30 | ||
| BG112045 | 2015-06-30 | ||
| PCT/GB2015/052362 WO2016024129A1 (en) | 2014-08-15 | 2015-08-14 | Mycobacterium tuberculosis proteins |
Related Child Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020140576A Division JP2020198886A (ja) | 2014-08-15 | 2020-08-24 | 結核菌（Ｍｙｃｏｂａｃｔｅｒｉｕｍ ｔｕｂｅｒｃｕｌｏｓｉｓ）タンパク質 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2017526742A JP2017526742A (ja) | 2017-09-14 |
| JP2017526742A5 true JP2017526742A5 (https=) | 2018-09-20 |
| JP6781698B2 JP6781698B2 (ja) | 2020-11-04 |
Family
ID=53969374
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2017527980A Active JP6781698B2 (ja) | 2014-08-15 | 2015-08-14 | 結核菌（Ｍｙｃｏｂａｃｔｅｒｉｕｍ ｔｕｂｅｒｃｕｌｏｓｉｓ）タンパク質 |
| JP2020140576A Pending JP2020198886A (ja) | 2014-08-15 | 2020-08-24 | 結核菌（Ｍｙｃｏｂａｃｔｅｒｉｕｍ ｔｕｂｅｒｃｕｌｏｓｉｓ）タンパク質 |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2020140576A Pending JP2020198886A (ja) | 2014-08-15 | 2020-08-24 | 結核菌（Ｍｙｃｏｂａｃｔｅｒｉｕｍ ｔｕｂｅｒｃｕｌｏｓｉｓ）タンパク質 |
Country Status (6)
| Country | Link |
|---|---|
| US (1) | US10295538B2 (https=) |
| EP (1) | EP3180353B1 (https=) |
| JP (2) | JP6781698B2 (https=) |
| CN (1) | CN107110862B (https=) |
| ES (1) | ES2897933T3 (https=) |
| WO (1) | WO2016024129A1 (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN106442983B (zh) * | 2016-08-31 | 2018-07-03 | 中国疾病预防控制中心传染病预防控制所 | 结核分枝杆菌抗原蛋白Rv3793及其T细胞表位肽的应用 |
| CN106248936B (zh) * | 2016-08-31 | 2018-09-25 | 中国疾病预防控制中心传染病预防控制所 | 结核分枝杆菌抗原蛋白Rv2201及其T细胞表位肽的应用 |
| JP7370598B2 (ja) * | 2018-05-02 | 2023-10-30 | 国立大学法人 新潟大学 | ペプチド及びその使用 |
| BR112023006262A2 (pt) | 2020-10-06 | 2023-05-09 | Cepheid | Métodos de diagnóstico de tuberculose e de diferenciação entre tuberculose ativa e latente |
| GB202101078D0 (en) * | 2021-01-27 | 2021-03-10 | Oxford Immunotec Ltd | Fragment pools |
| CN114736276B (zh) * | 2022-05-24 | 2023-08-01 | 中国人民解放军总医院第八医学中心 | 结核分枝杆菌ltbi-rd相关蛋白抗原的ctl表位肽及其应用 |
| CN115957312B (zh) * | 2023-01-17 | 2026-03-31 | 武汉大学 | B4galt1在制备抗结核分枝杆菌感染的药物中的应用 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2005508613A (ja) * | 2001-07-04 | 2005-04-07 | ヘルス プロテクション エージェンシー | 潜伏中に発現されるマイコバクテリア抗原 |
| WO2004099771A1 (en) * | 2003-05-08 | 2004-11-18 | Statens Serum Institut | A new specific epitope based immunological diagnosis of tuberculosis |
| ITRM20040091A1 (it) * | 2004-02-19 | 2004-05-19 | Istituto Naz Per Le Malattie | Test immunologico rapido per la diagnosi ed il monitoraggio dell'infezione tubercolare. |
| GB0406271D0 (en) * | 2004-03-19 | 2004-04-21 | Isis Innovation | Diagnostic test |
| WO2006000045A1 (en) | 2004-06-25 | 2006-01-05 | Proteome Systems Intellectual Property Pty Ltd | Novel methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor i |
| WO2007131293A1 (en) | 2006-05-16 | 2007-11-22 | Proteome Systems Limited | Methods of diagnosis and treatment of m. tuberculosis infection and reagents therefor vi |
| US7776341B2 (en) * | 2006-08-10 | 2010-08-17 | Colorado State University Research Foundation | Biomarkers of tuberculosis that distinguish disease categories: use as serodiagnostic antigens |
| AU2009273132B2 (en) | 2008-07-25 | 2015-09-03 | Glaxo Group Limited | The tuberculosis Rv2386c protein, compositions and uses thereof |
| MX344052B (es) * | 2009-05-13 | 2016-12-02 | Immport Therapeutics Inc | Composiciones y metodos para antigenos inmunodominantes de mycobacterium tuberculosis. |
| CN103884847B (zh) | 2014-03-14 | 2015-08-26 | 中国科学院生物物理研究所 | 一种结核分枝杆菌全蛋白质芯片及应用 |
-
2015
- 2015-08-14 JP JP2017527980A patent/JP6781698B2/ja active Active
- 2015-08-14 WO PCT/GB2015/052362 patent/WO2016024129A1/en not_active Ceased
- 2015-08-14 ES ES15753982T patent/ES2897933T3/es active Active
- 2015-08-14 US US15/503,151 patent/US10295538B2/en active Active
- 2015-08-14 EP EP15753982.6A patent/EP3180353B1/en active Active
- 2015-08-14 CN CN201580056106.6A patent/CN107110862B/zh active Active
-
2020
- 2020-08-24 JP JP2020140576A patent/JP2020198886A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2017526742A5 (https=) | ||
| RU2695462C2 (ru) | Гибридизация гетероолигомерных микобактериальных антигенов | |
| TWI638829B (zh) | 分枝桿菌抗原疫苗 | |
| EP2912056B1 (en) | M. tuberculosis vaccines | |
| Geluk et al. | Innovative strategies to identify M. tuberculosis antigens and epitopes using genome-wide analyses | |
| Santoro et al. | Transcriptomics of the vaccine immune response: priming with adjuvant modulates recall innate responses after boosting | |
| Coppola et al. | Vaccines for leprosy and tuberculosis: opportunities for shared research, development, and application | |
| US10004793B2 (en) | M.tuberculosis vaccines | |
| Geluk et al. | A multistage-polyepitope vaccine protects against Mycobacterium tuberculosis infection in HLA-DR3 transgenic mice | |
| Counoupas et al. | Mycobacterium tuberculosis components expressed during chronic infection of the lung contribute to long-term control of pulmonary tuberculosis in mice | |
| RU2016133598A (ru) | Композиция микобактериального антигена | |
| JP2016508143A5 (https=) | ||
| Leung-Theung-Long et al. | A multi-antigenic MVA vaccine increases efficacy of combination chemotherapy against Mycobacterium tuberculosis | |
| Maybeno et al. | Polyfunctional CD4+ T cell responses to immunodominant epitopes correlate with disease activity of virulent Salmonella | |
| Seidel et al. | BNT162b2 booster after heterologous prime-boost vaccination induces potent neutralizing antibodies and T cell reactivity against SARS-CoV-2 Omicron BA. 1 in young adults | |
| Kong et al. | A novel vaccine p846 encoding Rv3615c, Mtb10. 4, and Rv2660c elicits robust immune response and alleviates lung injury induced by Mycobacterium infection | |
| Hu et al. | A multistage Sendai virus vaccine incorporating latency-associated antigens induces protection against acute and latent tuberculosis | |
| JP2014519311A5 (https=) | ||
| CN105829891B (zh) | 用于改进的体内或体外细胞介导的结核病免疫诊断的诊断试剂 | |
| Wang et al. | PPE protein (Rv3425) from DNA segment RD11 of Mycobacterium tuberculosis: a novel immunodominant antigen of Mycobacterium tuberculosis induces humoral and cellular immune responses in mice | |
| WO2016077525A3 (en) | Human anti-thyroglobulin t cell receptors | |
| JP2021503276A5 (https=) | ||
| Nagai et al. | Immunological Responses and Epitope Mapping by Tuberculosis‐Associated Antigens within the RD1 Region in Japanese Patients | |
| CN103804499B (zh) | 一种检测结核分枝杆菌特异性免疫应答的试剂及其用途 | |
| Yamashita et al. | Multicolor flow cytometric analyses of CD4+ T cell responses to Mycobacterium tuberculosis-related latent antigens |